Prestige Consumer Healthcare Inc (NYSE:PBH) Receives $68.83 Average PT from Analysts

Share on StockTwits

Shares of Prestige Consumer Healthcare Inc (NYSE:PBH) have received a consensus rating of “Hold” from the ten research firms that are covering the company, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, seven have issued a hold rating and one has issued a buy rating on the company. The average 12 month price target among analysts that have updated their coverage on the stock in the last year is $68.83.

Several research firms have recently commented on PBH. ValuEngine lowered shares of Prestige Consumer Healthcare from a “sell” rating to a “strong sell” rating in a research report on Thursday, July 2nd. Sidoti upgraded shares of Prestige Consumer Healthcare from a “neutral” rating to a “buy” rating and set a $46.00 target price on the stock in a research report on Monday, June 29th. Oppenheimer restated a “hold” rating on shares of Prestige Consumer Healthcare in a research report on Wednesday, June 17th. TD Securities raised their target price on shares of Prestige Consumer Healthcare from $90.00 to $97.00 and gave the stock a “hold” rating in a research report on Friday, July 24th. Finally, BMO Capital Markets raised their target price on shares of Prestige Consumer Healthcare from $91.00 to $95.00 and gave the stock a “market perform” rating in a research report on Friday, July 24th.

Shares of PBH stock traded down $0.31 during trading hours on Monday, hitting $35.80. The company’s stock had a trading volume of 263,558 shares, compared to its average volume of 471,885. The business has a fifty day moving average of $36.51 and a 200-day moving average of $38.06. The stock has a market cap of $1.80 billion, a price-to-earnings ratio of 11.97, a P/E/G ratio of 2.90 and a beta of 0.77. Prestige Consumer Healthcare has a twelve month low of $27.40 and a twelve month high of $46.12. The company has a current ratio of 2.24, a quick ratio of 1.35 and a debt-to-equity ratio of 1.32.

Prestige Consumer Healthcare (NYSE:PBH) last released its quarterly earnings results on Thursday, August 6th. The company reported $0.86 EPS for the quarter, beating the consensus estimate of $0.70 by $0.16. The business had revenue of $229.40 million for the quarter, compared to analyst estimates of $221.27 million. Prestige Consumer Healthcare had a net margin of 15.84% and a return on equity of 13.81%. The company’s quarterly revenue was down 1.2% on a year-over-year basis. During the same period in the prior year, the business earned $0.65 earnings per share. On average, equities analysts expect that Prestige Consumer Healthcare will post 3.15 EPS for the current fiscal year.

Several institutional investors and hedge funds have recently made changes to their positions in the business. Two Sigma Advisers LP acquired a new position in shares of Prestige Consumer Healthcare in the 2nd quarter valued at $1,735,000. Principal Financial Group Inc. boosted its holdings in shares of Prestige Consumer Healthcare by 4.5% in the 2nd quarter. Principal Financial Group Inc. now owns 191,057 shares of the company’s stock valued at $7,176,000 after purchasing an additional 8,249 shares during the last quarter. PNC Financial Services Group Inc. boosted its holdings in shares of Prestige Consumer Healthcare by 4.7% in the 2nd quarter. PNC Financial Services Group Inc. now owns 7,015 shares of the company’s stock valued at $264,000 after purchasing an additional 313 shares during the last quarter. Handelsbanken Fonder AB acquired a new position in shares of Prestige Consumer Healthcare in the 2nd quarter valued at $405,000. Finally, AQR Capital Management LLC boosted its holdings in shares of Prestige Consumer Healthcare by 179.9% in the 2nd quarter. AQR Capital Management LLC now owns 384,266 shares of the company’s stock valued at $14,245,000 after purchasing an additional 247,001 shares during the last quarter.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) healthcare and household cleaning products in North America, Australia, and internationally. It operates in three segments: North American OTC Healthcare, International OTC Healthcare, and Household Cleaning.

Featured Story: If I purchase shares through a brokerage account, am I the holder of record?

Analyst Recommendations for Prestige Consumer Healthcare (NYSE:PBH)

Receive News & Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply